3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
18
Lymphoma
12
Lymphoma, Non-Hodgkin
11
Leukemia, Lymphocytic, Chronic, B-Cell
11
Lymphoma, Mantle-Cell
10
Lymphoma, Follicular
10
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma, B-Cell
4
Leukemia, Hairy Cell
4
Burkitt Lymphoma
4
Recurrence
3
Neoplasms
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoproliferative Disorders
2
Leukemia, B-Cell
2
Infections
2
Epstein-Barr Virus Infections
2
beta-Thalassemia
1
Thalassemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphatic Diseases
1
Lymphadenopathy
1
Interventions
Tretinoin
2
Carboplatin
2
durvalumab
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Azacitidine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Rituximab
×
30 days
×
Clear all
No trials found.